Cardiovascular Manifestations

The 30-month results of the phase 3 ATTRibute-CM trial provide the latest insight into the effects of acoramidis in people with transthyretin amyloid cardiomyopathy…

Purpose: To measure left ventricular (LV) myocardial strain with cine magnetic resonance (MR) imaging and a deformable registration algorithm (DRA) and to assess…

Background: The heart rate (HR) response to paced deep breathing (DB) is a common test of cardiac autonomic function, where high heart rate variability (HRV) is…

Objectives: Light-chain (AL) amyloidosis can lead to an infiltrative cardiomyopathy with increased wall thickness (IWT) of very poor prognosis. Our primary aim was…

Amyloidosis is an increasingly recognized cause of heart disease, caused by the deposition of misfolded protein within the heart. These proteins may deposit…

The most widely used system is the European modification of the original 3-stage Mayo 2004 system which uses Troponin T or I and NT-pro-BNP to divide patients into…

W. H. Wilson Tang, MD, is Research Director, and staff cardiologist in the Section of Heart Failure and Cardiac Transplantation Medicine in the Sydell and Arnold…

Randall C. Starling, MD, MPH, FACC, FESC is a member of the Section of Heart Failure and Cardiac Transplant Medicine, the Medical Director of the Kaufman Center for…

Jerry Estep, MD, is the Chairman of Cardiology at the Cleveland Clinic Florida, Weston. He earned his medical degree from Baylor College of Medicine, Houston, Texas…

Professional skills of Roberto Coury Pedrosa include a broad background in clinical cardiology, with specific training and expertise in key research areas. During…